| Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomes X Carrillo, A Curos, R Muga, J Serra, A Sanvisens, A Bayes-Genis European heart journal 32 (10), 1244-1250, 2011 | 88 | 2011 |
| Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study L Botta, G Gatta, R Capocaccia, C Stiller, A Cañete, L Dal Maso, K Innos, ... The Lancet Oncology 23 (12), 1525-1536, 2022 | 64 | 2022 |
| Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987–2001 R Muga, A Sanvisens, F Bolao, J Tor, J Santesmases, R Pujol, C Tural, ... Drug and Alcohol Dependence 82, S29-S33, 2006 | 61 | 2006 |
| Differences between alcoholic and nonalcoholic patients with Wernicke encephalopathy: a multicenter observational study AJ Chamorro, B Rosón-Hernández, JA Medina-García, ... Mayo Clinic Proceedings 92 (6), 899-907, 2017 | 58 | 2017 |
| Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART B Lumbreras, I Jarrín, J del Amo, S Pérez-Hoyos, R Muga, ... Aids 20 (1), 111-116, 2006 | 57 | 2006 |
| Impact of medical comorbidity and risk of death in 680 patients with alcohol use disorders I Rivas, A Sanvisens, F Bolao, D Fuster, J Tor, R Pujol, M Torrens, ... Alcoholism: Clinical and Experimental Research 37, E221-E227, 2013 | 55 | 2013 |
| Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study S Serrano-Villar, J Martínez-Sanz, R Ron, A Talavera-Rodríguez, ... The lancet HIV 7 (8), e565-e573, 2020 | 48 | 2020 |
| Long-term mortality of patients with an alcohol-related Wernicke–Korsakoff syndrome A Sanvisens, P Zuluaga, D Fuster, I Rivas, J Tor, M Marcos, AJ Chamorro, ... Alcohol and Alcoholism 52 (4), 466-471, 2017 | 45 | 2017 |
| Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus C Tural, J Tor, A Sanvisens, N Pérez–Alvarez, E Martínez, I Ojanguren, ... Clinical Gastroenterology and Hepatology 7 (3), 339-345, 2009 | 45 | 2009 |
| Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex-and age-specific survival of HIV-uninfected IDUs R Muga, K Langohr, J Tor, A Sanvisens, I Serra, C Rey-Joly, A Munoz Clinical Infectious Diseases 45 (3), 370-376, 2007 | 43 | 2007 |
| Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections D Fuster, A Sanvisens, F Bolao, I Rivas, J Tor, R Muga World journal of hepatology 8 (31), 1295, 2016 | 42 | 2016 |
| Metabolic syndrome among individuals with heroin use disorders on methadone therapy: Prevalence, characteristics, and related factors G Vallecillo, MJ Robles, M Torrens, P Samos, A Roquer, PK Martires, ... Substance abuse 39 (1), 46-51, 2018 | 39 | 2018 |
| COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study C Díez, J Del Romero‐Raposo, R Mican, JC López, JR Blanco, ... HIV medicine 22 (9), 867-876, 2021 | 33 | 2021 |
| Folate deficiency in patients seeking treatment of alcohol use disorder A Sanvisens, P Zuluaga, M Pineda, D Fuster, F Bolao, J Juncà, J Tor, ... Drug and Alcohol Dependence 180, 417-422, 2017 | 32 | 2017 |
| Overall and cause‐specific mortality in HIV‐positive subjects compared to the general population B Alejos, V Hernando, J López‐Aldeguer, F Segura, JA Oteo, R Rubio, ... Journal of the International AIDS Society 17, 2014 | 32 | 2014 |
| Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis C R Muga, A Sanvisens, D Fuster, J Tor, E Martínez, S Pérez-Hoyos, ... Public Library of Science 7 (10), e46810, 2012 | 31 | 2012 |
| Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER) A Riveros Frutos, S Holgado, A Sanvisens Bergé, I Casas, A Olivé, ... Rheumatology 60 (4), 1793-1803, 2021 | 30 | 2021 |
| Hyaluronic acid, transforming growth factor‐β1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co‐infection A Sanvisens, I Serra, C Tural, J Tor, I Ojanguren, E Barluenga, ... Journal of Viral Hepatitis 16 (7), 513-518, 2009 | 30 | 2009 |
| Markers of inflammation and mortality in a cohort of patients with alcohol dependence D Fuster, A Sanvisens, F Bolao, P Zuluaga, I Rivas, J Tor, R Muga Medicine 94 (10), e607, 2015 | 29 | 2015 |
| Progression of liver fibrosis in HIV/hepatitis C virus‐coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline R Sanmartin, J Tor, A Sanvisens, JJ Lopez, A Jou, R Muga, I Ojanguren, ... HIV medicine 15 (4), 203-212, 2014 | 29 | 2014 |
